Evidence-Based Medicine Guidelines
Intravenous immunoglobulin for Guillain-Barré syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intravenous Immunoglobulin for Guillain-Barré Syndrome." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/451719/all/__________Intravenous_immunoglobulin_for_Guillain_Barré_syndrome______.
Intravenous immunoglobulin for Guillain-Barré syndrome. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/451719/all/__________Intravenous_immunoglobulin_for_Guillain_Barré_syndrome______. Accessed December 2, 2023.
Intravenous immunoglobulin for Guillain-Barré syndrome. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/451719/all/__________Intravenous_immunoglobulin_for_Guillain_Barré_syndrome______
Intravenous Immunoglobulin for Guillain-Barré Syndrome [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 December 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/451719/all/__________Intravenous_immunoglobulin_for_Guillain_Barré_syndrome______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intravenous immunoglobulin for Guillain-Barré syndrome
ID - 451719
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451719/all/__________Intravenous_immunoglobulin_for_Guillain_Barré_syndrome______
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
